Abstract P115 Table 1

1- Baseline patient characteristics (n =10 )
Age (years)	22.3 years
Female Sex	8 (80%)
SLE diagnosis duration	3.8 years
History of hypertension	2 (20%)
History of DM	0 (0%)
Previous cardiac history	0 (0%)
2- Clinical data
Onset of LM	LN and LM			LN preceding LM
	6 (60%)			4 (40%)
Clinical presentation	Cardiogenic shock	Acute heart failure			Syncope
	4 (40%)	5 (50%)			1 (10%)
3- Laboratory and renal biopsy data
CBC	HB level			8.7 gm/dl
	Wbcs count			6.1 10^3/μl
	Platelets count			199 10^3/μl
Creatinine level	2.6 mg/dl
Protein: Creatinine ratio	3.6 mg/mg
Patients with renal biopsy	5 (50%)
	Class III		Class IV
	1 (20%)		4 (80%)
4- Baseline Echocardiography
LVEF	26.3%
ESD	46.1 mm
EDD	56.3 mm
Global hypokinesia	9 (90%)
Mitral regurgitation	10 (100%)
Tricuspid regurgitation	8 (80%)
Pericardial effusion	7 (70%)
Pulmonary hypertension	4 (40%)
5- Management
Pulse steroids	10 (100%)
IV cyclophosphamide	7 (70%)
mycophenolate mofetil	3 (30%)
Immunoadsorption	1 (10%)
6- Follow-up echocardiography after 3 months
LVEF	42.8%
ESD	38.9 mm
EDD	52 mm
7- Outcomes
Complete recovery	4 (40%)
Partial improvement	2 (20%)
Mortality	3 (30%)